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We report 3 patients with laboratory-conﬁ  rmed  Bu-
ruli ulcer in Kafufu/Luremo, Angola, and Kasongo-Lunda, 
Democratic Republic of Congo. These villages are near the 
Kwango/Cuango River, which ﬂ  ows through both countries. 
Further investigation of artisanal alluvial mining as a risk 
factor for Buruli ulcer is recommended.
B
uruli ulcer (BU), which is caused by the bacterium 
Mycobacterium ulcerans, is an indolent necrotizing 
disease of skin, subcutaneous tissue, and bone. BU is the 
third most common mycobacterial disease of humans, after 
tuberculosis and leprosy (1,2). Africa is the most affected 
continent, particularly in its tropical, central, and western 
regions (1).
BU was ﬁ  rst reported in the Democratic Republic of 
Congo (DRC) in 1950 (1). The disease has been reported 
in 5 of 11 provinces in DRC (Lower Congo, Bandundu, 
Maniema, Katanga, and South-Kivu) (3).
BU was ﬁ  rst reported in Angola in Caxito, Bengo 
Province, in 1998 (Figure) (4). Reports of BU in newly ar-
rived Angolan refugees at Kimpese (Lower Congo) since 
the 1960s (5) suggest that Angola has long been an area 
endemic for BU. However, no cases have been reported 
along the Kwango/Cuango River in DRC or Angola. 
This river, known as the Kwango River in DRC and the 
Cuango River in Angola, is the boundary between Angola 
and DRC from Luremo to Kasongo-Lunda (Bandundu 
Province) (Figure).
This study describes 3 laboratory-conﬁ  rmed cases of 
BU. These cases were most likely acquired near the Kwan-
go/Cuango River.
The Study
We studied 3 patients suspected of having BU who 
were admitted to the Dr Lelo Medical Center in Kinshasa 
(patient 1) and the Mother Teresa Buruli Ulcer Treatment 
Center in Kinshasa (patients 2 and 3). The study was re-
viewed and approved by the ethics committee of the Insti-
tute of Tropical Medicine, Antwerp, and the Public Health 
School of the Kinshasa University, Kinshasa, Ministère de 
l’Enseignement. The 3 patients provided verbal consent to 
participate in the study. Patients 1 and 2 were men 30 and 
28 years of age, respectively, and patient 3 was a girl 13 
years of age.
Characteristics of the patients are shown in the Table. 
Laboratory tests were performed on surgically excised tis-
sues and exudates according to World Health Organization 
(WHO) recommendations (6). Patients were treated with 
rifampin and streptomycin for 12 weeks according to WHO 
recommendations (7). Four weeks after the beginning of 
treatment, surgical debridement was performed, followed 
by split-skin grafting. The patients were followed up at the 
2 treatment centers and were considered cured when the 
lesions had completely healed.
All patients were residents of Kinshasa (DRC) and had 
no contacts with areas endemic for BU before traveling to 
areas along the Kwango/Cuango River where the BU skin 
lesions ﬁ  rst appeared. However, all patients had frequent 
contact through alluvial diamond mining (patients 1 and 2) 
or domestic activities (patient 3) along the Kwango/Cuan-
DISPATCHES
1790  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 11, November 2008
Author afﬁ  liations: Institute of Tropical Medicine, Antwerp, Belgium 
(K. Kibadi, G. Anyo, P. Suykerbuyk, F. Portaels); University of Kin-
shasa, Kinshasa, Democratic Republic of Congo (K. Kibadi, M. 
Panda); Institut National de Recherche Biomédicale, Kinshasa (K. 
Kibadi, J.-J.M. Tamfum); University of Minho, Braga, Portugal (A.G. 
Fraga, A.L. Filho, J. Pedrosa); University of Kansas, Lawrence, 
Kansas, USA (Y. Nakazawa); USA; and Armed Forces Institute of 
Pathology, Washington, DC, USA (W.M. Meyers)
DOI: 10.3201/eid1411.071649
Figure. Locations in Democratic Republic of Congo (DRC) 
(Kasongo-Lunda) and Angola (Kafufu/Luremo) where 3 patients 
with Buruli ulcer were detected.Buruli Ulcer, Angola and DRC
go River in DRC (Kasongo-Lunda) or in Angola (Kafufu/
Luremo) (Figure).
Patients reported that their lesions had started 2–2.5 
years earlier as nodules that later ulcerated. These patients 
were ﬁ  rst treated locally near the Kwango/Cuango River 
by traditional healers and with 2% Dakin ﬂ  uid (sodium hy-
pochlorite solution) to cleanse the wounds. These measures 
were unsuccessful, and the patients returned to Kinshasa 
for treatment at the 2 medical centers, where they were ad-
mitted in September 2004 (patient 1), June 2005 (patient 2), 
and July 2005 (patient 3).
On admission, all 3 patients had large ulcers (150–896 
cm2). Patient 1 had an ulcer on the right thigh, patient 2 
on the right arm, and patient 3 on the left leg (Table). BU 
was conﬁ  rmed by Ziehl-Neelsen staining for acid-fast ba-
cilli and a positive IS2404 PCR result (Table). Cultures re-
mained negative after incubation for 12 months at 32°C. 
For patient 3, BU was also conﬁ  rmed by histopathologic 
analysis performed before treatment. A specimen showed a 
predominantly neutrophilic inﬂ  ammatory inﬁ  ltrate near ex-
tensive areas of necrosis associated with calciﬁ  cation and 
clumps of extracellular acid-fast bacilli.
The 3 patients were considered cured after 3, 6, and 7 
months, respectively, of hospitalization. No relapses were 
observed after follow-up periods of 42, 30, and 28 months, 
respectively.
Conclusions
BU patients in our study had advanced disease with 
ulcers >10 cm in diameter. They were cured by treatment 
with antimicrobial drugs and surgery in accordance with 
WHO recommendations for treatment of BU (6,7). The pa-
tients were most likely infected during alluvial mining and 
use of water from the Kwango/Cuango River for domestic 
activities. Artisanal diamond mining in alluvial deposits 
along river banks consists of informal digging with basic 
equipment (often with unprotected hands and feet). Miners 
often work for long periods extracting diamonds from allu-
vial deposits along river banks. In Angola, mining areas are 
located in swamps that border the Kwango/Cuango River. 
Water sources used for domestic purposes along this slow-
ﬂ  owing river are unprotected, and proper hygienic proce-
dures are lacking.
Epidemiologic studies have established a close asso-
ciation of BU and wetlands, especially those with slow-
ﬂ  owing or stagnant water (ponds, backwaters, and swamps) 
(8–10). In Uganda and in Benin, use of unprotected sources 
of water for domestic purposes increased the risk for con-
tracting BU (10–12). Environmental factors, including 
poor hygienic conditions, along the Kwango/Cuango River 
make this region an area of high risk for contracting BU 
(10,13).
Studies have linked increased incidence of BU to hu-
man-made modiﬁ  cations such as expanded agricultural ac-
tivities, deforestation, or construction of dams (14). Activi-
ties of both large mining enterprises and individual miners 
are responsible for environmental changes that may play 
a role in increased incidence of BU. Diamond-mining pits 
may become pools of stagnant waters that are a dangerous 
source of waterborne diseases.
In the 1950s in the Belgian Congo (now DRC), several 
cases of BU were reported in alluvial gold miners work-
ing in the mining camp of Kakerifu between the Nzoro 
and Kibali Rivers (1). Currently, in the gold-mining area 
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Table. Characteristics of 3 Buruli ulcer patients infected along the Kwango/Cuango River, DRC and Angola* 
Characteristic Patient 1  Patient 2  Patient 3 
Age, y, sex  30, M  28, M  13, F 
Origin Kinshasa, DRC Kinshasa, DRC  Kinshasa, DRC 
Location where infected  Kafufu/Luremo, Angola  Kafufu/Luremo, Angola  Kasongo-Lunda, DRC 
Patient delay,† y  2 2.5 2.5
  Date of first symptoms  2002 Oct  2003 Jan  2003 Jan 
  Date care was sought  2004 Sep  2005 Jun  2005 Jul 
Lesion
 Type  Ulcer Ulcer Ulcer
 Size,  cm
2 320 150 896
  Site  Right thigh  Right arm  Left leg 
Test results 
 Ziehl-Neelsen  staining  + + +
 Culture  – – –
 IS2404 PCR  + + +
  Histopathologic changes  ND ND Extensive areas of necrosis with 
clumps of AFB 
Duration of hospitalization, mo  3 6 7
Follow-up period with no relapse, mo  42 30 28
Outcome Cured Cured Cured
*DRC, Democratic Republic of Congo; +, positive; –, negative; IS, insertion sequence; ND, not done; AFB, acid-fast bacilli. 
†Time between appearance of first signs or symptoms and care being sought at a medical center. of Amansie West District in Ghana, many BU infections 
occur among workers in contiguous alluvial mining opera-
tions (15). Diamond mines along the Cuango River in An-
gola may have inﬂ  uenced the emergence of BU cases along 
this river basin. However, whether the Cuango River ﬂ  ood-
plain is a region endemic for BU or if this region became 
endemic after diamond-mining activities is not known.
The frequency of BU in Angola is not documented 
partly because of political changes after the country’s in-
dependence in 1975. Surveys are urgently needed to deter-
mine the endemicity of BU in Angola. Our ﬁ  ndings empha-
size the need for further investigation of diamond, gold, and 
any other gemstone mining as a risk factor for contracting 
BU, particularly in West and Central Africa, where mining 
is common. All areas along the Kwango/Cuango River in 
DRC and Angola should be investigated for foci of BU. 
The association of artisanal alluvial mining with BU draws 
attention to a disease that further diminishes the quality of 
life of persons who are already living under the precarious 
circumstances experienced by those who mine diamonds.
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